SGLT2 inhibitor for secondary prevention in acute myocardial infarction patients with diabetes mellitus

被引：0
作者：
Kim, D. B. [1 ]
Kim, H. Y. [1 ]
机构：
[1] Catholic Univ Korea, Seoul, South Korea
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] SGLT2 Inhibitors for the Primary and Secondary Prevention
    Pavlicek, Vojtech
    DIABETOLOGE, 2019, 15 (01): : 47 - 49
  • [32] Empagliflozin, an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus: A Review of the Evidence
    White, John R., Jr.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (05) : 582 - 598
  • [33] Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus
    Casper H Jørgensen
    Gunnar H Gislason
    Ole Ahlehoff
    Charlotte Andersson
    Christian Torp-Pedersen
    Peter R Hansen
    BMC Cardiovascular Disorders, 14
  • [34] Positive effects of SGLT2 inhibitors on cardiac markers after acute myocardial infarction are similar in patients with and without type 2 diabetes
    Aziz, Faisal
    Oulhaj, Abderrahim
    Tripolt, Norbert
    Pferschy, Peter
    von-Lewinski, Dirk
    Sourij, Harald
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S752 - S753
  • [35] RENAL EFFECTS AND NEPHROPROTECTION INDUCED BY THE SGLT2 INHIBITOR EMPAGLIFLOZIN IN PATIENTS WITH DIABETES MELLITUS: A LITERATURE REVIEW
    Morales-Buenrostro, Luis E.
    Citlali Juarez-Comboni, Sonia
    Aldrete Velasco, Jorge
    Rodriguez Alcocer, Alma Nelly
    REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE, 2017, 37 (01): : 48 - 61
  • [36] LUSEOGLIFLOZIN SGLT2 Inhibitor Treatment of Diabetes
    Tiwari, A.
    DRUGS OF THE FUTURE, 2012, 37 (09) : 637 - 643
  • [37] SGLT2 Inhibitors in Type 2 Diabetes Mellitus
    Ferrannini, Giulia
    Savarese, Gianluigi
    Cosentino, Francesco
    HEART FAILURE CLINICS, 2022, 18 (04) : 551 - 559
  • [38] Comparison of SGLT2 inhibitors versus DPP-4 inhibitors as combination with metformin in patients with acute myocardial infarction with diabetes
    Lyu, Y.
    Oh, S.
    Kim, J.
    Jeong, M.
    Kim, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S474 - S475
  • [39] Effect of the SGLT2 Inhibitor Dapagliflozin on Potassium Levels in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis
    Yshai Yavin
    Traci A. Mansfield
    Agata Ptaszynska
    Kristina Johnsson
    Shamik Parikh
    Eva Johnsson
    Diabetes Therapy, 2016, 7 : 125 - 137
  • [40] THE SGLT2 INHIBITOR DAPAGLIFLOZIN IMPROVES ERECTILE DYSFUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PROSPECTIVE STUDY
    Cannarella, Rossella
    Condorelli, Rosita A. Angela
    Leanza, Claudia
    Garofalo, Vincenzo
    Lundy, Scott
    Calogero, Aldo E.
    La Vignera, Sandro
    FERTILITY AND STERILITY, 2023, 120 (04) : E245 - E246
12345